Analysis of market trend of Human Albumin and Coagulation factors in India

Abstract

The present study has been conducted atNational Institute of Biologicals (NIB), NOIDA to analyse the status of Human Serum Albumin (HSA) and other human plasma derived products and their availability in Indian market. The samples of albumin, human coagulation factor VIII and factor IX, both indigenously manufactured and imported, which were received in the Institute during financial years FY 2012-13 to 2017-18.The present study showed that there was no change in the number of indigenously manufactured HSA samples received in 2013-14 and 2014-15 afterwards the data showed gradually decline in viz. of 29% in the 2015-16 and further by 84% in 2016-17.It was observed that there is a gap between supply and demand of plasma fractionation products as most of them are imported. The non-availability of quality domestic plasma fraction has led to dependence on imported plasma for production of indigenously manufactured plasma products.Strong reforms in regulations and Health Policies within the country as well as globally is the key to address the situation and achieve the target of self-sufficiency in indigenous production of plasma based medicinal products.